Karyopharm Therapeut (KPTI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 168,004 | 75,545 | 83,506 | 118,021 | 101,600 |
| Marketable Securities | 99,525 | 141,614 | 180,918 | 210,178 | 105,170 |
| Receivables | 7,928 | N/A | N/A | N/A | N/A |
| Inventories | 100 | N/A | N/A | N/A | N/A |
| TOTAL | $280,867 | $222,830 | $271,435 | $334,612 | $211,562 |
| Non-Current Assets | |||||
| PPE Net | 3,240 | 3,375 | 3,617 | 3,863 | 2,914 |
| Investments And Advances | 2,022 | 0 | 0 | 2,001 | 4,804 |
| Other Non-Current Assets | 11,616 | 11,895 | 12,162 | 716 | 712 |
| TOTAL | $16,878 | $15,270 | $15,779 | $6,580 | $8,430 |
| Total Assets | $297,745 | $238,100 | $287,214 | $341,192 | $219,992 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,068 | 1,113 | 2,266 | 4,332 | 2,238 |
| Accrued Expenses | 32,421 | 27,799 | 28,868 | 32,493 | 29,155 |
| Other current liabilities | 1,077 | 453 | 701 | 327 | 556 |
| TOTAL | $39,202 | $32,174 | $43,860 | $46,904 | $41,567 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,053 | 1,287 | 10,650 | 9,752 | 9,618 |
| Other Non-Current Liabilities | 195,194 | 120,212 | 118,825 | 102,664 | 0 |
| TOTAL | $198,673 | $123,457 | $122,070 | $111,118 | $7,347 |
| Total Liabilities | $237,875 | $155,631 | $165,930 | $158,022 | $48,914 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,188 | 4,130 | 4,060 | 4,059 | 4,049 |
| Common Shares | 6 | 6 | 6 | 6 | 6 |
| Retained earnings | -824,691 | -783,324 | -739,909 | -673,748 | -615,538 |
| Other shareholders' equity | -30 | 61 | -28 | -244 | -153 |
| TOTAL | $59,870 | $82,469 | $121,284 | $183,170 | $171,078 |
| Total Liabilities And Equity | $297,745 | $238,100 | $287,214 | $341,192 | $219,992 |